140 related articles for article (PubMed ID: 38814)
1. [Neuroleptics and the extrapyramidal system].
Haase HJ
Arzneimittelforschung; 1978; 28(9):1536-7. PubMed ID: 38814
[No Abstract] [Full Text] [Related]
2. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
Vatsek Ia
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940
[No Abstract] [Full Text] [Related]
3. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
Möller HJ; Kissling W
Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
[No Abstract] [Full Text] [Related]
4. Use of novel antipsychotic drugs.
Raleigh F
Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
[TBL] [Abstract][Full Text] [Related]
5. Extrapyramidal side effects: a historical perspective.
Rifkin A
J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
[TBL] [Abstract][Full Text] [Related]
6. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
Johnson DA
Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
[No Abstract] [Full Text] [Related]
7. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
8. The effect of octoclothepine on sensorimotor coordination of fine movements in chronic schizophrenics.
Remr J
Act Nerv Super (Praha); 1972; 14(2):90-1. PubMed ID: 5040177
[No Abstract] [Full Text] [Related]
9. [Treatment of schizophrenia].
Houy-Durand E; Thibaut F
Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics in the treatment of schizophrenia. Paper underrates patients' experience of extrapyramidal symptoms.
Kerwin R
BMJ; 2001 Apr; 322(7291):926-7; author reply 927-8. PubMed ID: 11302914
[No Abstract] [Full Text] [Related]
11. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
12. The handwriting test as an aid to neuroleptic dosage.
Küstner U; Müller-Oerlinghausen B
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S34-41. PubMed ID: 2878893
[No Abstract] [Full Text] [Related]
13. [Neuroleptics and extrapyramidal effects from the biochemical viewpoint. Discussion by the Workshop on Neuroleptics and the Extrapyramidal System].
Seyfried C
Arzneimittelforschung; 1978; 28(9):1537-8. PubMed ID: 38815
[No Abstract] [Full Text] [Related]
14. [Sensory disorders arising during neuroleptic therapy].
Rovinskaia SA; Revva LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):905-9. PubMed ID: 6106339
[TBL] [Abstract][Full Text] [Related]
15. Depot neuroleptics: side effects and safety.
Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
[TBL] [Abstract][Full Text] [Related]
16. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
Elizur A; Segal S; Yeret A; Ben-David M
Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
[No Abstract] [Full Text] [Related]
17. [Schizophrenia: adverse effects of atypical neuroleptics].
Bettina Polk B
Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
[No Abstract] [Full Text] [Related]
18. [A practical guide for the use of psychopharmacologic agents. II. Antipsychotic and antiparkinson agents].
Chouinard G
Union Med Can; 1976 Sep; 105(9):1387-97. PubMed ID: 9720
[No Abstract] [Full Text] [Related]
19. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
Moritz S; Krausz M; Gottwalz E; Andresen B
Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
[TBL] [Abstract][Full Text] [Related]
20. Appearance of extrapyramidal symptoms: interaction between neuroleptics and other CNS active drugs.
Fregnan GB; Vidali M
Pharmacology; 1982; 25(2):102-10. PubMed ID: 6127727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
